These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11716290)

  • 1. Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c.
    Jakus V; Bauerová K; Michalková D; Cársky J
    Diabetes Nutr Metab; 2001 Aug; 14(4):207-11. PubMed ID: 11716290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
    Kostolanská J; Jakus V; Barák L
    J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
    Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A
    J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus.
    Jakus V; Bauerova K; Michalkova D; Carsky J
    Bratisl Lek Listy; 2000; 101(9):484-9. PubMed ID: 11187050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.
    Berg TJ; Dahl-Jørgensen K; Torjesen PA; Hanssen KF
    Diabetes Care; 1997 Jun; 20(6):1006-8. PubMed ID: 9167115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Formation of Serum Advanced Glycation End-Products in Children with Type 1 Diabetes Mellitus: Relationship with Glycemic Control.
    Jaisson S; Souchon PF; Desmons A; Salmon AS; Delemer B; Gillery P
    J Pediatr; 2016 May; 172():56-62. PubMed ID: 26947567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of serum/plasma glycation and lipid peroxidation of young patients with type 1 diabetes mellitus in relation to glycemic compensation and the occurrence of diabetic complications.
    Kostolanska J; Jakus V; Barak L; Stanikova A; Waczulikova I
    Bratisl Lek Listy; 2010; 111(11):578-85. PubMed ID: 21384742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
    Turk Z; Mesić R; Benko B
    Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of early and advanced glycation in relation to the occurrence of microvascular complications in children and adolescents with type 1 diabetes mellitus.
    Kostolanská J; Jakus V; Barák L
    Physiol Res; 2009; 58(4):553-561. PubMed ID: 18657005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating TGF-β1, glycation, and oxidation in children with diabetes mellitus type 1.
    Jakuš V; Sapák M; Kostolanská J
    Exp Diabetes Res; 2012; 2012():510902. PubMed ID: 23049541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
    Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
    Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
    Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
    Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
    Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.
    Brunvand L; Heier M; Brunborg C; Hanssen KF; Fugelseth D; Stensaeth KH; Dahl-Jørgensen K; Margeirsdottir HD
    BMC Cardiovasc Disord; 2017 May; 17(1):133. PubMed ID: 28545398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.
    Berg TJ; Bangstad HJ; Torjesen PA; Osterby R; Bucala R; Hanssen KF
    Metabolism; 1997 Jun; 46(6):661-5. PubMed ID: 9186302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of HbA1C, glycated serum proteins and albumin, and fructosamine with the 24-h glucose profile of insulin-dependent pregnant diabetics.
    Suhonen L; Stenman UH; Koivisto V; Teramo K
    Clin Chem; 1989 Jun; 35(6):922-5. PubMed ID: 2731364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitus.
    Koga M; Suzuki S; Matsuo K; Tanahashi Y; Azuma H; Kasayama S
    Clin Chim Acta; 2013 Oct; 425():188-91. PubMed ID: 23933122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.